Susquehanna International Group
BTTX

Susquehanna International Group’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Susquehanna International Group’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,057
Closed -$7.42K – 13957
2023
Q4 		$7.42K Buy
+38,057
New +$8.27K ﹤0.01% 12097
2023
Q2 		– Sell
-47,516
Closed -$34.6K – 13680
2023
Q1 		$34.6K Sell
47,516
-6,473
-12% -$7.6K ﹤0.01% 11856
2022
Q4 		$60.5K Sell
53,989
-17,477
-24% -$25.8K ﹤0.01% 11286
2022
Q3 		$126K Buy
71,466
+3,084
+5% +$5.63K ﹤0.01% 11468
2022
Q2 		$107K Buy
+68,382
New +$114K ﹤0.01% 11421
2022
Q1 		– Hold
0
– – – 14499
2021
Q4 		– Sell
-14,067
Closed -$115K – 14418
2021
Q3 		$140K Buy
+14,067
New +$140K ﹤0.01% 11844

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return